Table 1. 23 top hits that show >80% inhibition and 5 additional compounds of interest.

	hM1-CAF			hM1-2D
Drug Name	Final EC50 (M)	Averaged Max % Response	StdDev Max % Response	Final EC50 (M)	Averaged Max % Response	StdDev Max % Response
Dasatinib	58.9E-9	80	0.58	9.4E-9	83.75	0.35
Mithramycin	157.6E-9	93	2.56	174.1E-9	89.32	0.56
Teniposide	74.7E-9	94	0.50	482.6E-9	89.59	1.74
Methylrosanilinium	499.3E-9	101	0.06	489.1E-9	93.04	0.98
Gemcitabine	1.7E-9	96	9.21E-3	760.6E-12	93.78	0.29
Dactinomycin	3.8E-9	99	0.67	1.7E-9	94.30	0.29
Aclarubicin	610.8E-9	96	0.30	475.1E-9	94.77	0.76
Emetine	182.3E-9	100	0.18	118.3E-9	94.99	0.33
Epirubicin	84.5E-9	97	0.51	179.1E-9	95.41	0.84
Daunorubicin	38.8E-9	98	0.31	100.4E-9	95.59	0.60
Homoharringtonine	17.1E-9	99	0.20	14.1E-9	96.16	0.31
Topotecan	32.6E-9	97	0.08	312.8E-9	96.72	0.81
Idarubicin	10.7E-9	97	0.34	72.2E-9	96.85	0.51
Doxorubicin	90.6E-9	100	0.15	181.6E-9	96.89	1.07
Disulfiram	184.8E-9	59	12.08	316.6E-9	97.93	1.01
Dipyrithione magnesium sulfate	459.6E-9	93	6.61	428.8E-9	98.97	0.18
Bortezomib	1.4E-9	99	0.13	2.3E-9	99.25	0.14
Carfilzomib	2.6E-9	101	0.13	4.E-9	99.39	0.06
Romidepsin	952.8E-12	100	0.11	701.E-12	99.55	0.10
Auranofin	684.E-9	99	0.21	400.9E-9	99.55	0.07
Phanquinone	310.3E-9	99	1.14	105.8E-9	99.68	0.22
Thiram	596.4E-9	82	7.34	386.8E-9	100.10	0.07
Tyrothricin	407.2E-9	101	9.98E-3	491.5E-9	100.92	0.09
Afatinib	2.8E-6	94	3.05	226.3E-9	78.23	2.26
Neratinib	5.E-6	34	6.04	516.3E-9	67.78	1.49
Trametinib	5.E-6	38	5.35	2.7E-9	70.89	0.65
Oxaliplatin	5.E-6	11	2.82	5.E-6	10.49	2.86
Fluorouracil	5.E-6	33	9.34	5.E-6	45.58	2.18